Investors' Chronicle
Investors' Chronicle
Looking to stay informed in the world of investing? Investors' Chronicle dives into the key trends shaping today’s markets and unpacks what they mean for your investments. Featuring exclusive interviews with professional investors - whether fund managers or leading financial experts - our mission is to help you make smarter investment decisions.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Our award-winning expert writers research hundreds of companies and funds suitable for all risk appetites, to provide clear, independent recommendations for individual investors who want to make their money grow and outline how to make the most of different types of investment vehicles at all stages of your life.Whether you invest in funds or enjoy managing your own portfolio of individual shares, or a mix of both, we offer an unrivalled package of investment ideas, analysis and research, and lots more, to help you build a secure financial future.Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Episodes
Mentioned books
Apr 27, 2017 • 34min
Companies & Markets Show: Aim's top stocks
Companies editor Ian Smith and guests discuss the latest ructions for energy companies alongside our review of Aim's top stocks including a look at BooHoo vs Asos and some of Aim's favourite oil stocksInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 26, 2017 • 19min
The Price of Drugs: Investing amid pharma's politics
Drug pricing always comes with political noise, particularly when US elections are concerned. Over the last year, the share prices of pharmaceutical and biotech companies on both sides of the Atlantic have continually swung on the tweets and proclamations of politicians.In this special podcast, IC companies writer Megan Boxall speaks with industry insiders and tries to cut through the controversy and policy rumblings, to assess whether there are still good reasons to view pharma and biotech companies as worthwhile investments. Produced by Alex Newman and Dominic Toms, with music from Blue Dot Sessions. News clips courtesy of Fox.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 25, 2017 • 23min
Boardroom Talk: The risk and reward of UBM's events focus
UBM started life as a newspaper company, and spent most of the last century building up its media and PR operations. But diversification is no longer the watchword. Three years ago, the company chose to concentrate on its global events business.The share price, and the special returns, show investors have benefited from that decision, but where does the investment case stand now? An acquisition-led growth model has lifted sales but also balance sheet leverage, while comparable sales have been slow in some geographies.UBM chief executive Tim Cobbold fields questions on the group's strategy from IC companies editor Ian Smith. Produced by Dominic Toms and Alex Newman.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 21, 2017 • 19min
Personal Finance Show: 21 April 2017
On this week's Personal Finance Show the team is joined by Rachel Winter, investment manager at Killik & Co. They ask whether you should go for the new three-year NS&I Investment Guaranteed Growth Bond. Its interest rate of 2.2 per cent trumps everything on the high street but it is already lagging the rate of inflation. Should you invest anyway?The team also talks inflation-beating asset allocation and high yields from frontier and emerging markets. Deputy personal finance editor Kate Beioley explores the income potential and potential hazards of frontier market investing.Finally Emma Agyemang looks at specialist trust Impax Environmental Markets' (IEM). The trust has been shooting the lights out this year but is there a Trump-shaped cloud on the horizon for this green energy flavoured trust?Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 20, 2017 • 43min
Companies & Markets Show: AIMing High
IC editor John Hughman is joined by small companies guru Simon Thompson and companies editor Ian Smith to discuss why the Aim market remains a stockpicker's paradise, and why news of snap election could spell trouble for the FTSE 100.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 19, 2017 • 13min
Boardroom Talk: Applied Graphene Materials
Graphene and the hype surrounding atomic chicken wireMark Robinson talks to Gareth Jones (CFO) and Jon Mabbitt (CEO) of Applied Graphene Materials about the realistic options open to investors a decade down the line after the development of the so-called wonder material.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 12, 2017 • 25min
Companies & Markets Show: The great de-rigging
The North Sea, recruiters, Libor, but no mention of Brexit…Deputy companies editor Mark Robinson steps in for John Hughman in this week's look at the latest news and signals in equity markets. With news editor Emma Powell and natural resources writer Alex Newman.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 11, 2017 • 8min
Boardroom Talk: Primary Health Properties
Bringing doctor surgeries into the 21st century, with modern facilities and a wide range of services is going to coast billions of pounds. Ironically, it will save money because a hospital visit costs the NHS far more than a visit to a doctor’s surgery. Without further investment, the situation is likely to get worse because more and more people are living longer, and this is the age group that is more likely to need greater medical attention. One of the companies at the forefront of providing more modern medical centres is Primary Health Properties (PHP). In the latest edition of our Boardroom Talk series Jonas Crosland spoke to chief executive of Primary Health Properties Harry Hyman, to discuss what needs to be done to help take the burden away from hard pressed hospitals by providing dedicated medical centres to replace old GP surgeries that are not fit for purpose.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 7, 2017 • 28min
Personal Finance Show: New tax year
In this week's show Monica Tepes, director of investment companies research at Cantor Fitzgerald, joins the personal finance team to explain how investment trusts focused on alternative assets can generate a high income. They also set out the asset allocation models and funds you should be using in a Lifetime Isa, and explain how a new tax allowance could help to cut inheritance tax bills.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Apr 6, 2017 • 37min
Companies & Markets Show: Match-making and break-ups
Companies editor Ian Smith and the team discuss the week's takeover news, Imagination Technologies' Apple contract loss and RPC's bears.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
